Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response.

Dvornikov D, Schneider MA, Ohse S, Szczygieł M, Titkova I, Rosenblatt M, Muley T, Warth A, Herth FJ, Dienemann H, Thomas M, Timmer J, Schilling M, Busch H, Boerries M, Meister M, Klingmüller U.

Sci Rep. 2018 Jun 22;8(1):9517. doi: 10.1038/s41598-018-27912-1.

2.

The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC).

Muley T, Rolny V, He Y, Wehnl B, Escherich A, Warth A, Stolp C, Schneider MA, Dienemann H, Meister M, Herth FJ, Dayyani F.

Lung Cancer. 2018 Jun;120:46-53. doi: 10.1016/j.lungcan.2018.03.015. Epub 2018 Mar 17.

3.

Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-small-cell Lung Cancer.

Yamauchi Y, Safi S, Blattner C, Rathinasamy A, Umansky L, Juenger S, Warth A, Eichhorn M, Muley T, Herth FJF, Dienemann H, Platten M, Beckhove P, Utikal J, Hoffmann H, Umansky V.

Am J Respir Crit Care Med. 2018 Apr 4. doi: 10.1164/rccm.201708-1707OC. [Epub ahead of print]

PMID:
29617574
4.

[Implementation of Hyperthermic Intrathoracic Chemotherapy (HITHOC) in Germany].

Ried M, Hofmann HS, Dienemann H, Eichhorn M.

Zentralbl Chir. 2018 Jun;143(3):301-306. doi: 10.1055/a-0573-2419. Epub 2018 Mar 12. German.

PMID:
29529693
5.

FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas.

Milewski D, Balli D, Ustiyan V, Le T, Dienemann H, Warth A, Breuhahn K, Whitsett JA, Kalinichenko VV, Kalin TV.

PLoS Genet. 2017 Dec 21;13(12):e1007097. doi: 10.1371/journal.pgen.1007097. eCollection 2017 Dec.

6.

Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project.

Letovanec I, Finn S, Zygoura P, Smyth P, Soltermann A, Bubendorf L, Speel EJ, Marchetti A, Nonaka D, Monkhorst K, Hager H, Martorell M, Sejda A, Cheney R, Hernandez-Losa J, Verbeken E, Weder W, Savic S, Di Lorito A, Navarro A, Felip E, Warth A, Baas P, Meldgaard P, Blackhall F, Dingemans AM, Dienemann H, Dziadziuszko R, Vansteenkiste J, O'Brien C, Geiger T, Sherlock J, Schageman J, Dafni U, Kammler R, Kerr K, Thunnissen E, Stahel R, Peters S; European Thoracic Oncology Platform Lungscape Consortium.

J Thorac Oncol. 2018 Mar;13(3):413-425. doi: 10.1016/j.jtho.2017.11.117. Epub 2017 Nov 27.

PMID:
29191776
7.

C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.

Yamauchi Y, Safi S, Muley T, Warth A, Herth FJF, Dienemann H, Hoffmann H, Eichhorn ME.

Lung Cancer. 2017 Dec;114:62-67. doi: 10.1016/j.lungcan.2017.11.002. Epub 2017 Nov 3.

PMID:
29173768
8.

Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancer.

Safi S, Yamauchi Y, Rathinasamy A, Stamova S, Eichhorn M, Warth A, Rauch G, Dienemann H, Hoffmann H, Beckhove P.

Oncoimmunology. 2017 Sep 8;6(11):e1360458. doi: 10.1080/2162402X.2017.1360458. eCollection 2017.

PMID:
29147626
9.

Low-dose photon irradiation induces invasiveness through the SDF-1α/CXCR4 pathway in malignant mesothelioma cells.

Yamauchi Y, Safi S, Orschiedt L, Gardyan A, Brons S, Rieber J, Nicolay NH, Huber PE, Eichhorn M, Dienemann H, Herth FJF, Weber KJ, Debus J, Hoffmann H, Rieken S.

Oncotarget. 2017 Jul 10;8(40):68001-68011. doi: 10.18632/oncotarget.19134. eCollection 2017 Sep 15.

10.

Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.

Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, Chatterjee N, Thorleifsson G, Sulem P, Liu G, Kaaks R, Henrion M, Kinnersley B, Vallée M, Le Calvez-Kelm F, Stevens VL, Gapstur SM, Chen WV, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Gabrielsen ME, Skorpen F, Vatten L, Njølstad I, Chen C, Goodman G, Benhamou S, Vooder T, Välk K, Nelis M, Metspalu A, Lener M, Lubiński J, Johansson M, Vineis P, Agudo A, Clavel-Chapelon F, Bueno-de-Mesquita HB, Trichopoulos D, Khaw KT, Johansson M, Weiderpass E, Tjønneland A, Riboli E, Lathrop M, Scelo G, Albanes D, Caporaso NE, Ye Y, Gu J, Wu X, Spitz MR, Dienemann H, Rosenberger A, Su L, Matakidou A, Eisen T, Stefansson K, Risch A, Chanock SJ, Christiani DC, Hung RJ, Brennan P, Landi MT, Houlston RS, Amos CI.

Nat Genet. 2017 Mar 30;49(4):651. doi: 10.1038/ng0417-651a. No abstract available.

PMID:
28358128
11.

AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients.

Schneider MA, Christopoulos P, Muley T, Warth A, Klingmueller U, Thomas M, Herth FJ, Dienemann H, Mueller NS, Theis F, Meister M.

Int J Oncol. 2017 Feb;50(2):365-372. doi: 10.3892/ijo.2017.3834. Epub 2017 Jan 2.

12.

[Local treatment of solitary intrapulmonary, malignant nodules].

Op den Winkel J, Eichhorn F, Rieken S, Dienemann H.

Radiologe. 2017 Feb;57(2):97-104. doi: 10.1007/s00117-016-0200-0. Review. German.

PMID:
28054137
13.

Immune Response After Radiofrequency Ablation and Surgical Resection in Nonsmall Cell Lung Cancer.

Schneider T, Hoffmann H, Dienemann H, Herpel E, Heussel CP, Enk AH, Ring S, Mahnke K.

Semin Thorac Cardiovasc Surg. 2016 Summer;28(2):585-592. doi: 10.1053/j.semtcvs.2016.02.008. Epub 2016 Feb 23.

PMID:
28043482
14.

SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.

Herpel E, Rieker RJ, Dienemann H, Muley T, Meister M, Hartmann A, Warth A, Agaimy A.

Ann Diagn Pathol. 2017 Feb;26:47-51. doi: 10.1016/j.anndiagpath.2016.10.006. Epub 2016 Oct 20.

PMID:
28038711
15.

Typing of colon and lung adenocarcinoma by high throughput imaging mass spectrometry.

Kriegsmann M, Longuespée R, Wandernoth P, Mohanu C, Lisenko K, Weichert W, Warth A, Dienemann H, De Pauw E, Katzenberger T, Aust D, Baretton G, Kriegsmann J, Casadonte R.

Biochim Biophys Acta. 2017 Jul;1865(7):858-864. doi: 10.1016/j.bbapap.2016.11.018. Epub 2016 Dec 8.

PMID:
27939606
16.

A new classification method for MALDI imaging mass spectrometry data acquired on formalin-fixed paraffin-embedded tissue samples.

Boskamp T, Lachmund D, Oetjen J, Cordero Hernandez Y, Trede D, Maass P, Casadonte R, Kriegsmann J, Warth A, Dienemann H, Weichert W, Kriegsmann M.

Biochim Biophys Acta. 2017 Jul;1865(7):916-926. doi: 10.1016/j.bbapap.2016.11.003. Epub 2016 Nov 9.

PMID:
27836618
17.

A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.

Pecqueux M, Liebetrau I, Werft W, Dienemann H, Muley T, Pfannschmidt J, Müssle B, Rahbari N, Schölch S, Büchler MW, Weitz J, Reissfelder C, Kahlert C.

Int J Mol Sci. 2016 Oct 21;17(10). pii: E1755.

18.

Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.

Schneider MA, Muley T, Kahn NC, Warth A, Thomas M, Herth FJ, Dienemann H, Meister M.

Oncotarget. 2016 Nov 1;7(44):71285-71297. doi: 10.18632/oncotarget.12474.

19.

[Tracheobronchoplasty for Severe Diffuse Tracheomalacia].

Hoffmann H, Gompelmann D, Heußel CP, Dienemann H, Eberhardt R.

Zentralbl Chir. 2016 Sep;141 Suppl 1:S35-42. doi: 10.1055/s-0042-113193. Epub 2016 Sep 8. German.

PMID:
27607887
20.

Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis.

Chen LS, Baker T, Hung RJ, Horton A, Culverhouse R, Hartz S, Saccone N, Cheng I, Deng B, Han Y, Hansen HM, Horsman J, Kim C, Rosenberger A, Aben KK, Andrew AS, Chang SC, Saum KU, Dienemann H, Hatsukami DK, Johnson EO, Pande M, Wrensch MR, McLaughlin J, Skaug V, van der Heijden EH, Wampfler J, Wenzlaff A, Woll P, Zienolddiny S, Bickeböller H, Brenner H, Duell EJ, Haugen A, Brüske I, Kiemeney LA, Lazarus P, Le Marchand L, Liu G, Mayordomo J, Risch A, Schwartz AG, Teare MD, Wu X, Wiencke JK, Yang P, Zhang ZF, Spitz MR, Amos CI, Bierut LJ.

EBioMedicine. 2016 Sep;11:219-226. doi: 10.1016/j.ebiom.2016.08.012. Epub 2016 Aug 10.

21.

Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens.

Kriegsmann M, Casadonte R, Kriegsmann J, Dienemann H, Schirmacher P, Hendrik Kobarg J, Schwamborn K, Stenzinger A, Warth A, Weichert W.

Mol Cell Proteomics. 2016 Oct;15(10):3081-3089. Epub 2016 Jul 29.

22.

[A man who was sick of being sick].

Grigaliūnas G, Csernus R, Op den Winkel J, Herth F, Dienemann H, Kauczor HU, Heußel CP.

Med Klin Intensivmed Notfmed. 2016 Nov;111(8):734-736. Epub 2016 Jun 9. German. No abstract available.

PMID:
27279377
23.

Genetic changes of non-small cell lung cancer under neoadjuvant therapy.

Warth A, Endris V, Stenzinger A, Penzel R, Harms A, Duell T, Abdollahi A, Lindner M, Schirmacher P, Muley T, Dienemann H, Fink L, Morresi-Hauf A, Pfarr N, Weichert W.

Oncotarget. 2016 May 17;7(20):29761-9. doi: 10.18632/oncotarget.8858.

24.

Clinical Relevance of Different Papillary Growth Patterns of Pulmonary Adenocarcinoma.

Warth A, Muley T, Harms A, Hoffmann H, Dienemann H, Schirmacher P, Weichert W.

Am J Surg Pathol. 2016 Jun;40(6):818-26. doi: 10.1097/PAS.0000000000000622.

PMID:
26927890
25.

Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma.

Marien E, Meister M, Muley T, Gomez Del Pulgar T, Derua R, Spraggins JM, Van de Plas R, Vanderhoydonc F, Machiels J, Binda MM, Dehairs J, Willette-Brown J, Hu Y, Dienemann H, Thomas M, Schnabel PA, Caprioli RM, Lacal JC, Waelkens E, Swinnen JV.

Oncotarget. 2016 Mar 15;7(11):12582-97. doi: 10.18632/oncotarget.7179.

26.

Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).

Rieber J, Deeg A, Ullrich E, Foerster R, Bischof M, Warth A, Schnabel PA, Muley T, Kappes J, Heussel CP, Welzel T, Thomas M, Steins M, Dienemann H, Debus J, Hoffmann H, Rieken S.

Lung Cancer. 2016 Jan;91:41-7. doi: 10.1016/j.lungcan.2015.11.014. Epub 2015 Nov 25.

PMID:
26711933
27.

A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial).

Safi S, Beckhove P, Warth A, Benner A, Roeder F, Rieken S, Debus J, Dienemann H, Hoffmann H, Huber PE.

BMC Cancer. 2015 Dec 19;15:988. doi: 10.1186/s12885-015-2006-2.

28.

Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: a large scale study of 1465 non-small cell lung cancer cases.

Kriegsmann M, Muley T, Harms A, Tavernar L, Goldmann T, Dienemann H, Herpel E, Warth A.

Diagn Pathol. 2015 Dec 8;10:210. doi: 10.1186/s13000-015-0441-7.

29.

Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 cases.

Warth A, Körner S, Penzel R, Muley T, Dienemann H, Schirmacher P, von Knebel-Doeberitz M, Weichert W, Kloor M.

Virchows Arch. 2016 Mar;468(3):313-9. doi: 10.1007/s00428-015-1892-7. Epub 2015 Dec 4.

PMID:
26637197
30.

Proposal of a prognostically relevant grading scheme for pulmonary squamous cell carcinoma.

Weichert W, Kossakowski C, Harms A, Schirmacher P, Muley T, Dienemann H, Warth A.

Eur Respir J. 2016 Mar;47(3):938-46. doi: 10.1183/13993003.00937-2015. Epub 2015 Nov 5.

31.

NUT carcinoma of the thorax: Case report and review of the literature.

Harms A, Herpel E, Pfarr N, Penzel R, Heussel CP, Herth FJ, Dienemann H, Weichert W, Warth A.

Lung Cancer. 2015 Dec;90(3):484-91. doi: 10.1016/j.lungcan.2015.10.001. Epub 2015 Oct 9. Review.

PMID:
26490121
32.

The dynamic pattern of recurrence in curatively resected non-small cell lung cancer patients: Experiences at a single institution.

Yamauchi Y, Muley T, Safi S, Rieken S, Bischoff H, Kappes J, Warth A, Herth FJ, Dienemann H, Hoffmann H.

Lung Cancer. 2015 Nov;90(2):224-9. doi: 10.1016/j.lungcan.2015.09.010. Epub 2015 Sep 15.

PMID:
26415991
33.

High-throughput diagnostic profiling of clinically actionable gene fusions in lung cancer.

Pfarr N, Stenzinger A, Penzel R, Warth A, Dienemann H, Schirmacher P, Weichert W, Endris V.

Genes Chromosomes Cancer. 2016 Jan;55(1):30-44. doi: 10.1002/gcc.22297. Epub 2015 Sep 23.

PMID:
26394895
34.

Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia.

Brenner DR, Amos CI, Brhane Y, Timofeeva MN, Caporaso N, Wang Y, Christiani DC, Bickeböller H, Yang P, Albanes D, Stevens VL, Gapstur S, McKay J, Boffetta P, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Skorpen F, Gabrielsen ME, Vatten L, Njølstad I, Chen C, Goodman G, Lathrop M, Vooder T, Välk K, Nelis M, Metspalu A, Broderick P, Eisen T, Wu X, Zhang D, Chen W, Spitz MR, Wei Y, Su L, Xie D, She J, Matsuo K, Matsuda F, Ito H, Risch A, Heinrich J, Rosenberger A, Muley T, Dienemann H, Field JK, Raji O, Chen Y, Gosney J, Liloglou T, Davies MP, Marcus M, McLaughlin J, Orlow I, Han Y, Li Y, Zong X, Johansson M; EPIC Investigators, Liu G, Tworoger SS, Le Marchand L, Henderson BE, Wilkens LR, Dai J, Shen H, Houlston RS, Landi MT, Brennan P, Hung RJ.

Carcinogenesis. 2015 Nov;36(11):1314-26. doi: 10.1093/carcin/bgv128. Epub 2015 Sep 10.

35.

[Pulmonary Echinococcosis: Surgical Aspects].

Eichhorn ME, Hoffmann H, Dienemann H.

Zentralbl Chir. 2015 Oct;140 Suppl 1:S29-35. doi: 10.1055/s-0035-1557808. Epub 2015 Sep 9. Review. German.

PMID:
26351761
36.

Resection of thoracic malignancies infiltrating cardiac structures with use of cardiopulmonary bypass.

Arif R, Eichhorn F, Kallenbach K, Seppelt P, Ruhparwar A, Dienemann H, Karck M.

J Cardiothorac Surg. 2015 Jun 25;10:87. doi: 10.1186/s13019-015-0296-8.

37.

Sublobar Resection, Radiofrequency Ablation or Radiotherapy in Stage I Non-Small Cell Lung Cancer.

Safi S, Rauch G, op den Winkel J, Kunz J, Schneider T, Bischof M, Heussel CP, Huber PE, Herth FJ, Dienemann H, Hoffmann H.

Respiration. 2015;89(6):550-7. doi: 10.1159/000381555. Epub 2015 Apr 30.

38.

Glycodelin: A New Biomarker with Immunomodulatory Functions in Non-Small Cell Lung Cancer.

Schneider MA, Granzow M, Warth A, Schnabel PA, Thomas M, Herth FJ, Dienemann H, Muley T, Meister M.

Clin Cancer Res. 2015 Aug 1;21(15):3529-40. doi: 10.1158/1078-0432.CCR-14-2464. Epub 2015 Apr 21.

39.

Ion therapy within the trimodal management of superior sulcus tumors: the INKA trial.

Hauswald H, Rieken S, Dienemann HC, Thomas M, Kieser M, Debus J, Herfarth K.

BMC Cancer. 2015 Mar 28;15:192. doi: 10.1186/s12885-015-1163-7.

40.

CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.

Chen LS, Hung RJ, Baker T, Horton A, Culverhouse R, Saccone N, Cheng I, Deng B, Han Y, Hansen HM, Horsman J, Kim C, Lutz S, Rosenberger A, Aben KK, Andrew AS, Breslau N, Chang SC, Dieffenbach AK, Dienemann H, Frederiksen B, Han J, Hatsukami DK, Johnson EO, Pande M, Wrensch MR, McLaughlin J, Skaug V, van der Heijden HF, Wampfler J, Wenzlaff A, Woll P, Zienolddiny S, Bickeböller H, Brenner H, Duell EJ, Haugen A, Heinrich J, Hokanson JE, Hunter DJ, Kiemeney LA, Lazarus P, Le Marchand L, Liu G, Mayordomo J, Risch A, Schwartz AG, Teare D, Wu X, Wiencke JK, Yang P, Zhang ZF, Spitz MR, Kraft P, Amos CI, Bierut LJ.

J Natl Cancer Inst. 2015 Apr 14;107(5). pii: djv100. doi: 10.1093/jnci/djv100. Print 2015 May. Review.

41.

Development and validation of a risk score for predicting death after pneumonectomy.

Safi S, Benner A, Walloschek J, Renner M, op den Winkel J, Muley T, Storz K, Dienemann H, Hoffmann H, Schneider T.

PLoS One. 2015 Apr 9;10(4):e0121295. doi: 10.1371/journal.pone.0121295. eCollection 2015.

42.

Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.

Marien E, Meister M, Muley T, Fieuws S, Bordel S, Derua R, Spraggins J, Van de Plas R, Dehairs J, Wouters J, Bagadi M, Dienemann H, Thomas M, Schnabel PA, Caprioli RM, Waelkens E, Swinnen JV.

Int J Cancer. 2015 Oct 1;137(7):1539-48. doi: 10.1002/ijc.29517. Epub 2015 Apr 7.

43.

Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization.

Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, Schnabel PA, Eichinger M, Optazaite DE, Puderbach M, Wielpütz M, Kauczor HU, Tremper J, Delorme S.

J Thorac Oncol. 2015 Jun;10(6):890-6. doi: 10.1097/JTO.0000000000000530.

44.

[How to do - the chest tube drainage].

Klopp M, Hoffmann H, Dienemann H.

Dtsch Med Wochenschr. 2015 Mar;140(5):339-42. doi: 10.1055/s-0041-100725. Epub 2015 Mar 3. Review. German.

PMID:
25734676
45.

Prognostic Impact of Intra-alveolar Tumor Spread in Pulmonary Adenocarcinoma.

Warth A, Muley T, Kossakowski CA, Goeppert B, Schirmacher P, Dienemann H, Weichert W.

Am J Surg Pathol. 2015 Jun;39(6):793-801. doi: 10.1097/PAS.0000000000000409.

PMID:
25723114
46.

Questionable statement.

Dienemann H.

Dtsch Arztebl Int. 2015 Jan 30;112(5):70. doi: 10.3238/arztebl.2015.0070a. No abstract available.

47.

Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer.

Schneider T, Sevko A, Heussel CP, Umansky L, Beckhove P, Dienemann H, Safi S, Utikal J, Hoffmann H, Umansky V.

Clin Exp Immunol. 2015 Jun;180(3):467-74. doi: 10.1111/cei.12596. Epub 2015 Apr 15.

48.

Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma.

Warth A, Muley T, Kossakowski C, Stenzinger A, Schirmacher P, Dienemann H, Weichert W.

J Thorac Oncol. 2015 Apr;10(4):638-44. doi: 10.1097/JTO.0000000000000490.

49.

Predictors of survival after operation among patients with large cell neuroendocrine carcinoma of the lung.

Eichhorn F, Dienemann H, Muley T, Warth A, Hoffmann H.

Ann Thorac Surg. 2015 Mar;99(3):983-9. doi: 10.1016/j.athoracsur.2014.10.015. Epub 2015 Jan 14.

PMID:
25596870
50.

Invasive lung cancer staging: influence of CT-guided core needle biopsy on onset of pleural carcinomatosis.

Flechsig P, Kunz J, Heussel CP, Bozorgmehr F, Schnabel P, Dienemann H, Kauczor HU, Sedlaczek O.

Clin Imaging. 2015 Jan-Feb;39(1):56-61. doi: 10.1016/j.clinimag.2014.10.005. Epub 2014 Oct 16.

PMID:
25457543

Supplemental Content

Loading ...
Support Center